<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-pharmaceutics-10-00039">
 <label>57.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bauer</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Yang</surname>
    <given-names>X.</given-names>
   </name>
   <name>
    <surname>Hartz</surname>
    <given-names>A.M.S.</given-names>
   </name>
   <name>
    <surname>Olson</surname>
    <given-names>E.R.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Kalvass</surname>
    <given-names>J.C.</given-names>
   </name>
   <name>
    <surname>Pollack</surname>
    <given-names>G.M.</given-names>
   </name>
   <name>
    <surname>Miller</surname>
    <given-names>D.S.</given-names>
   </name>
  </person-group>
  <article-title>In vivo activation of human pregnane X receptor tightens the blood-brain barrier to methadone through P-glycoprotein up-regulation</article-title>
  <source>Mol. Pharmacol.</source>
  <year>2006</year>
  <volume>70</volume>
  <fpage>1212</fpage>
  <lpage>1219</lpage>
  <pub-id pub-id-type="doi">10.1124/mol.106.023796</pub-id>
  <?supplied-pmid 16837625?>
  <pub-id pub-id-type="pmid">16837625</pub-id>
 </element-citation>
</ref>
